Here's Why Crispr Therapeutics AG Jumped Again in February

Offhand comments from Gilead Sciences helped gave the high-flying gene-editing stock more lift.

…Read the rest of this story

Source:: https://finance.yahoo.com/news/apos-why-crispr-therapeutics-ag-163600406.html